The structure of an organic molecule revealed by atomic force microscopy.
window, some 150 to 200 million years in duration, when the basics of multicellular life emerged. Nearly one-third of the genetic alterations that distinguish humans from their last common ancestor with singlecelled organisms took place during this period. These changes would have occurred within our sponge-like forebears.
The researchers also identified parts of the genome devoted to suppressing individual cells that multiply at the expense of the collective. 
Breeding boost
Yields could be vastly improved by planting new Artemisia strains. On average, one kilogram of its dried leaves yields some 8 grams of artemisinin. But at the National Institute of Agricultural Botany in Cambridge, UK, researchers have used selective breeding to create hybrid plants that produce up to 24 grams, says Colin Hill, chair of an Artemisia breeding consortium supported by the UK Department for the Environment, Food and Rural Affairs. These plants are now being grown and harvested commercially in Madagascar, and trialled in South Africa, Uganda, Zimbabwe and the United States, as well as in Britain.
In an alternative approach, Ian Graham and colleagues at the University of York, UK, identified key Artemisia genes that could optimize agricultural yields, robustness or other desirable traits when the plant is grown in different areas of the globe (I. A. Graham et al. Science 327, 328-331; 2010) . Graham says that the work has helped to create plants that produce up to 50% more artemisinin per kilogram of leaves than the best commercial variety. They expect to release seed to commercial growers in mid-2012.
Despite the advances in plant biotechnology, Keasling says that semi-synthetic artemisinin is still sorely needed. Although it began as a way to make the drug more cheaply, the mass-produced semi-synthetic will be no cheaper than the plant-derived version -partly because Sanofi-aventis does not want to undercut farmers. Instead, it will be used to smooth out the cycle of boom and bust in crop-based artemisinin supply. "A stable and adequate source of artemisinin would be fundamentally important, " says Silvia Schwarte of the World Health Organization's malaria programme.
As Newman says: "If you suddenly need twice as much artemisinin, you just fire up another fermenter. " 
